Predictors for Dexmedetomidine Requirement for Sedation under Regional Anesthesia

(1) Background: This prospective observational study aimed to investigate the predictors affecting DMT requirements for sedation during regional anesthesia. (2) Method: A total of 108 patients who received regional anesthesia with intravenous DMT administration for orthopedic upper- or lower-extremity surgery were enrolled. Following successful regional anesthesia, DMT was administered at a rate of 4 µg/kg/h until reaching loss of consciousness (LOC). The administered dose of DMT per body weight until LOC (DMT_LOC; µg/kg) was evaluated. The infusion was maintained at a rate of 0.2–0.7 µg/kg/h during the surgery. At the end of surgery, the elapsed time to a BIS value of 90 (T_BIS90; s) was recorded. Linear regression models were used to identify potential predictors of DMT_LOC and T_BIS90. (3) Results: One hundred patients were analyzed. There were negative relationships between DMT_LOC and age (r = −0.297, p = 0.003) and DMT_LOC and body mass index (BMI) (r = −0.425, p < 0.001), respectively. Multiple linear regression models revealed that both increasing age and BMI were significantly related to DMT_LOC (r² = 0.259, p < 0.001), but those variables showed no association with T_BIS90. (4) Conclusions: The results of this study suggest that initial loading of DMT should be carefully titrated to minimize risk in elderly and obese surgical populations.